Stocks and Investing
Stocks and Investing
Thu, September 12, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, September 11, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Geoff Meacham Maintained (BBIO) at Strong Buy and Held Target at $42 on, Sep 11th, 2024
Geoff Meacham of B of A Securities, Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy and Held Target at $42 on, Sep 11th, 2024.
Geoff has made no other calls on BBIO in the last 4 months.
There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Geoff's Rating of Hold.
These are the ratings of the 6 analyists that currently disagree with Geoff
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, September 9th, 2024
- Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $46 on, Wednesday, September 4th, 2024
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Tuesday, September 3rd, 2024
- Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024
- Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
Contributing Sources